FDA Wants Tougher Warnings On TNF-Inhibitors
2 CommentsBy Ed Silverman // September 4th, 2008 // 11:48 am
• Pharma Blog » Archives
Johnson & Johnson
Director Of Controversial TMAP Program Leaves
5 CommentsBy Ed Silverman // September 4th, 2008 // 10:10 am
Hearty News From Europe’s Cardiology Meeting
Make a commentBy Ed Silverman // August 31st, 2008 // 10:36 am
Pharmalot… Pharmalittle… A Holiday Weekend
Make a commentBy Ed Silverman // August 29th, 2008 // 7:17 am
More Pharma Job Losses At UCB And J&J
Make a commentBy Ed Silverman // August 28th, 2008 // 7:47 am
Amgen Ends Some Aranesp Pricing Practices
Make a commentBy Ed Silverman // August 28th, 2008 // 7:23 am
Pharmalot… Pharmalittle… Morning Edition
Make a commentBy Ed Silverman // August 27th, 2008 // 8:27 am
FDA Wants More Info On J&J Drug For Pneumonia
Make a commentBy Ed Silverman // August 21st, 2008 // 8:44 am
Clinical Trials In India And 49 Infant Deaths
Make a commentBy Ed Silverman // August 20th, 2008 // 9:48 am